US Patent Issued to SHANGHAI AUCTA PHARMACEUTICALS on April 7 for "Lamotrigine hydrate crystal form, preparation method therefor, and composition containing same" (Chinese, American Inventors)

ALEXANDRIA, Va., April 7 -- United States Patent no. 12,595,237, issued on April 7, was assigned to SHANGHAI AUCTA PHARMACEUTICALS Co. LTD. (Shanghai).

"Lamotrigine hydrate crystal form, preparation method therefor, and composition containing same" was invented by Shoufeng Li (Piscataway, N.J.), Yong Wang (Shanghai) and Boli Li (Shanghai).

According to the abstract* released by the U.S. Patent & Trademark Office: "The present invention relates to a crystalline form of a lamotrigine hydrate, a method for preparing the same and a composition comprising the same, and in particular, to a lamotrigine hydrate form A, a method for preparing the lamotrigine hydrate form A and a composition comprising the lamotrigine hydrate form A."

The patent w...